参考文献/References:
[1] Kurimoto Y,Shimomura Y,Moriyama K,et al. Suppressive effects of the neutrophil elastase inhibitor sivelestat sodium hydrate on interleukin-1β production in lipopolysaccharide-stimulated porcine whole blood[J].Fujita Med J,2020,6(1):12-16.
[2] He YQ,Zhou CC,Yu LY,et al. Natural product derived phytochemicals in managing acute lung injury by multiple mechanisms[J].Pharmacol Res,2021,163:105224.
[3] Kolilekas L,Loverdos K,Giannakaki S,et al. Can steroids reverse the severe COVID-19 induced "cytokine storm"?[J].J Med Virol,2020,92(11):2866-2869.
[4] Yamaguchi K,Sugasawa Y,Takeuchi K,et al. Effects of sivelestat on bronchial inflammatory responses after esophagectomy[J]. Int J Mol Med,2011,28(2):187-192.
[5] Gao X,Zhang R,Lei Z,et al. Efficacy,safety,and pharmacoeconomics of sivelestat sodium in the treatment of septic acute respiratory distress syndrome:a retrospective cohort study[J]. Ann Palliat Med,2021,10(11):11910-11917.
[6] 马静,李长力,赵聪源等. 西维来司他钠联合气道压力释放通气治疗创伤所致重度ARDS的临床疗效观察[J]. 临床研究,2024,32(2):49-52.
[7] Pan T,Tuoerxun T,Chen X,et al. The neutrophil elastase inhibitor,sivelestat,attenuates acute lung injury in patients with cardiopulmonary bypass[J]. Front Immunol,2023,14:1082830.
[8] Aikawa N, Ishizaka A, Hirasawa H, et al. Reevaluation of the efficacy and safety of the neutrophil elastase inhibitor, Sivelestat, for the treatment of acute lung injury associated with systemic inflammatory response syndrome; a phase IV study.?Pulm Pharmacol Ther. 2011;24(5):549-554.
[9] Zhang H,Zeng J,Li J,et al. Sivelestat sodium attenuates acute lung injury by inhibiting JNK/NF-κB and activating Nrf2/HO-1 signaling pathways[J]. Biomol Biomed,2023,23(3):457-470.
[10] Jin Q,Liu KJ,Zhong CH,et al. Sivelestat sodium alleviated sepsis-induced acute lung injury by inhibiting TGF-β/Smad signaling pathways through upregulating microRNA-744-5p[J].J Thorac Dis,2024,16(10):6616-6633.
[11] 王后红,李国刚,李超,等. 西维来司钠对急性坏死性胰腺炎肺损伤保护作用及其机制研究[J]. 中华急诊医学杂,2016,25(1):63-66.
[12] Wang J,Wu Y,Mao M,et al. Sivelestat sodium alleviates ischemia-reperfusion-induced acute kidney injury via suppressing TLR4/Myd88/NF-κB signaling pathway in mice[J].Drug Des Devel Ther,2024,18:4449-4458.
[13] Aune SE,Yeh ST,Kuppusamy P,et al. Sivelestat attenuates myocardial reperfusion injury during brief low flow postischemic infusion[J].Oxid Med Cell Longev,2013,2013:279847.
[14] Fujii M, Bessho R. Neutrophil Elastase Inhibitor Sivelestat Attenuates Myocardial Injury after Cardioplegic Arrest in Rat Hearts[J].Ann Thorac Cardiovasc Surg,2020,26(5):263-269.
[15] 高小新,张如俊,田佳,等. 西维来司他钠对LPS诱导大鼠心肌细胞损伤的保护作用[J]. 中国医学创新,2024,21(33):171-174.
[16] Ding Q,Wang Y,Yang C,et al. Clinical Utility of the Sivelestat for the Treatment of ALI/ARDS: Moving on in the Controversy?[J]. Intensive Care Res,2023,3(1):12-17.
[17] Liu R,He A,Xu Y,et al. In vitro atomization analysis and evaluation of inhalable sodium sivelestat formulations [J].PLoS One,2024,19(9):e0309721.
[18] Jufar AH,Lankadeva YR,May CN,et al. Renal and cerebral hypoxia and inflammation during cardiopulmonary bypass[J].Compr Physiol,2021,12(1):2799-2834.
[19] Steinbrenner H,Bilgic E,Pinto A,et al. Selenium pretreatment for mitigation of ischemia/reperfusion injury in cardiovascular surgery:influence on acute organ damage and inflammatory response[J].Inflammation,2016,39(4):1363-1376.
[20] Wan S,LeClerc JL,Vincent JL. Inflammatory response to cardiopulmonary bypass:mechanisms involved and possible therapeutic strategies [J].Chest,1997,112(3):676-692.
[21] 潘渝,陈金,张松松等. 西维来司他钠在体外循环瓣膜置换术中肺保护作用研究[J]. 系统医学,2023,8(9):47-51.
[22] 王晓博,周俊辉,钟巍等. 西维来司他钠对体外循环下心脏瓣膜置换术老年患者术后早期康复的影响[J]. 西部医学,2024,36(1):108-113+119.
[23] Inoue N,Oka N,Kitamura T,et al. Neutrophil elastase inhibitor sivelestat attenuates perioperative inflammatory response in pediatric heart surgery with cardiopulmonary bypass[J]. Int Heart J,2013;54(3):149-153.
[24] 王宇航. 西维来司他钠对21例单纯二尖瓣置换患者体外循环术后相关肺损伤的临床疗效分析[D]. 长春:吉林大学,2023.
[25] Kawahito K,Adachi H,Ino T. Influence of surgical procedures on interleukin-6 and monocyte chemotactic and activating factor responses:CABG vs.valvular surgery[J].J Interferon Cytokine Res,2000,20(1):1-6.
[26] Beer L,Szerafin T,Mitterbauer A,et al. Continued mechanical ventilation during coronary artery bypass graft operation attenuates the systemic immune response[J]. Eur J Cardiothorac Surg,2013,44(2):282-287.
[27] 白军锋,马鹏飞,朱燕等. 西维来司他钠对体外循环下冠脉搭桥患者术后呼吸功能保护效应:一项单中心回顾性队列研究[J]. 空军军医大学学报,2023,44(8):721-725.
[28] Wang TKM,Wei D,Evans T,et al. Surgery for type a aortic dissection:14-year contemporary cohort study[J]. Heart Lung Circ,2020,29(8):1210-1216.
[29] Evangelista A,Isselbacher EM,Bossone E,et al. Insights from the international registry of acute aortic dissection:a 20-year experience of collaborative clinical research[J].Circulation,2018,137(17):1846-1860.
[30] Pape LA,Awais M,Woznicki EM,et al. Presentation,diagnosis,and?outcomes of?acute aortic dissection:17-year trends from the international registry of acute aortic dissection[J].J Am Coll Cardiol,2015,66(4),350-358.
[31] 吴光玲,刘斯卿,周俊辉,等. 西维来司他钠对急性Stanford A型主动脉夹层手术患者围术期急性肺损伤影响的探讨[J]. 中国临床新医学,2023,16(9):913-919.
[32] 曹先通,吴玉静,胡佳文等. 西维来司他钠对急性A型主动脉夹层术后急性呼吸功能不全及全身炎症反应的疗效观察[J]. 中国体外循环杂志,2022,20(4):216-220.
[33] Morimoto N,Morimoto K,Morimoto Y,et al. Sivelestat attenuates postoperative pulmonary dysfunction after total arch replacement under deep hypothermia[J].?Eur J Cardiothorac Surg,2008,34(4):798-804.
[34] Nomura N,Asano M,Saito T,et al. Sivelestat attenuates lung injury in surgery for congenital heart disease with pulmonary hypertension[J].Ann Thorac Surg,2013,96(6):2184-2191.
[35] Toyama S,Hatori F,Shimizu A,et al. A neutrophil elastase inhibitor, sivelestat, improved respiratory and cardiac function in pediatric cardiovascular surgery with cardiopulmonary bypass[J].J Anesth,2008,22(4):341-346.
[36] Pang XY,Fang CC,Chen YY,et al. Effects of ulinastatin on perioperative inflammatory response and pulmonary function in cardiopulmonary bypass patients[J].Am J Ther,2016,23(6):e1680-e1689.
[37] Xu HY,Rong XS,Wang DP,et al. Effect of urinary trypsin inhibitor on inflammatory cytokines and organ function in patients with cardiopulmonary bypass[J]. Eur Rev Med Pharmacol Sci,2017,21(9):2220-2225.
[38] 樊敬峰. 西维来司他钠对重症脑卒中患者血乳酸、CRP及TGF-β_1的影响研究[J]. 中国现代药物应用,2023,17(18):94-97.
[39] 陆通安,苏丽娟,彭演国,等. 西维来司他钠联合乌司他丁治疗急性肺损伤/急性呼吸窘迫综合征的疗效及安全性[J]. 临床合理用药杂志,2022,15(36):84-87.
[40] Dvirnik N,Belley-Cote EP,Hanif H,et al. Steroids in cardiac surgery:a systematic review and meta-analysis[J]. Br J Anaesth,2018,120(4):657-667.
[41] 孙同文,张海涛. 西维来司他钠临床应用专家共识[J]. 中国研究型医院,2022,9(1):9-13.
[42] 孙同文,张西京,黎毅敏,等. 中国成人急性呼吸窘迫综合征(ARDS)诊断与非机械通气治疗指南(2023)[J]. 中国研究型医院,2023,10(5):9-24.
[43] 张懋,洪春巧. 西维来司他钠联合气道压力释放通气治疗创伤所致重度急性呼吸窘迫综合征的临床效果[J]. 临床合理用药,2023,16(34):57-59.
[44] 许艳军,许铁,刘朋等. 西维来司他钠联合气道压力释放通气治疗创伤所致重度ARDS的疗效及对血气、炎性因子和预后的影响[J]. 疑难病杂志,2021,20(12):1215-1219.
相似文献/References:
[1]焦若男 张海涛.成人心脏外科术后乳糜胸的研究进展[J].心血管病学进展,2020,(12):1264.[doi:10.16806/j.cnki.issn.1004-3934.2020.12.010]
Jiao Ruonan,Zhang Haitao.Chylothorax Complicating Adult Cardiac Surgery Procedures[J].Advances in Cardiovascular Diseases,2020,(9):1264.[doi:10.16806/j.cnki.issn.1004-3934.2020.12.010]
[2]于文波 廖晨曦 张健 翟波.体外膜肺氧合在婴幼儿先天性心脏病术后应用的研究进展[J].心血管病学进展,2021,(7):632.[doi:10.16806/j.cnki.issn.1004-3934.2021.07.014]
YU Wenbo,LIAO Chenxi,ZHANG Jian,et al.Extracorporeal Membrane Oxygenation in Infants with Congenital Heart Disease after Operation[J].Advances in Cardiovascular Diseases,2021,(9):632.[doi:10.16806/j.cnki.issn.1004-3934.2021.07.014]
[3]宋爵麟 侯江龙.成人心脏手术胸骨正中入路术后胸骨闭合技术的研究进展[J].心血管病学进展,2022,(6):499.[doi:10.16806/j.cnki.issn.1004-3934.2022.06.006]
ONG JuelinHOU Jianglong.Sternal Closure Technique?fter Median Sternotomy in Adult Cardiac Surgery[J].Advances in Cardiovascular Diseases,2022,(9):499.[doi:10.16806/j.cnki.issn.1004-3934.2022.06.006]
[4]阿布都赛米·艾尼 阿布都乃比·麦麦提艾力.全腔镜技术在心脏外科手术中的应用进展[J].心血管病学进展,2023,(4):293.[doi:10.16806/j.cnki.issn.1004-3934.2023.04.002]
Abudousaimi·AiniAbudounaibi·Maimaitiaili?/html>.Current Progress in the Application of?otally Thoracoscopic Techniques in Cardiac Surgery[J].Advances in Cardiovascular Diseases,2023,(9):293.[doi:10.16806/j.cnki.issn.1004-3934.2023.04.002]
[5]董捷 杜楚豪 董硕 刘顺 徐海涛 孙阳雪 邹孟轩 孙家树 李守军 杨克明 闫军.Uhl畸形诊断与治疗研究进展[J].心血管病学进展,2023,(8):686.[doi:10.16806/j.cnki.issn.1004-3934.2023.08.004]
DONG Jie DU Chuhao DONG ShuoLIU Shun,XU HaitaoSUN YangxueZOU MengxuanSUN JiashuLI Shoujun,YANG Keming,et al.Diagnosis and Treatment for Uhls Anomaly[J].Advances in Cardiovascular Diseases,2023,(9):686.[doi:10.16806/j.cnki.issn.1004-3934.2023.08.004]
[6]陶红 沈骁 章淬.心脏术后新发心房颤动的研究进展[J].心血管病学进展,2024,(3):234.[doi:10.16806/j.cnki.issn.1004-3934.2024.03.010]
TAO Hong,SHEN Xiao,ZHANG Cui.Postoperative Atrial Fibrillation After Cardiac Surgery[J].Advances in Cardiovascular Diseases,2024,(9):234.[doi:10.16806/j.cnki.issn.1004-3934.2024.03.010]
[7]车千秋 赵丽明 李洪卫.心脏康复在心血管疾病中的应用及前景展望[J].心血管病学进展,2025,(6):495.[doi:10.16806/j.cnki.issn.1004-3934.2025.06.004]
CHE Qianqiu,ZHAO Liming,LI Hongwei.The Application and Prospects of Cardiac Rehabilitation?n Cardiovascular Diseases[J].Advances in Cardiovascular Diseases,2025,(9):495.[doi:10.16806/j.cnki.issn.1004-3934.2025.06.004]